Similar Articles
1421 Risk factors for residual tumor after resection of hepatocellular carcinoma
1422 Intraductal papillary neoplasm of the bile duct in liver cirrhosis with hepatocellular carcinoma
1423 Therapeutic options for intermediate-advanced hepatocellular carcinoma
1424 β-catenin accumulation in nuclei of hepatocellular carcinoma cells up-regulates glutathione-s-transferase M3 mRNA
1425 Portal vein thrombosis and arterioportal shunts: Effects on tumor response after chemoembolization of hepatocellular carcinoma
1426 Body mass index is associated with age-at-onset of HCV-infected hepatocellular carcinoma patients
1427 A potential oncogenic role of the commonly observed E2F5 overexpression in hepatocellular carcinoma
1428 Multicentric occurrence of hepatocellular carcinoma with nonalcoholic steatohepatitis
1429 First multicenter study for risk factors for hepatocellular carcinoma development in North Africa
1430 Hepatocellular carcinoma xenograft supports HCV replication: A mouse model for evaluating antivirals
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA